Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01079897

Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis Clinical Trial

Official title:
A Randomized, Comparator-controlled, Double-blind, Multicenter Intra-individual Clinical Trial to Evaluate the Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis

Clinical Trial Summary

This study evaluates the efficacy of the topical used ectoine-formulation EHK02-01 compared to Atopiclair. Patients are examined at visit 2 (baseline visit). The patient topically applies EHK02-01 or Zarzenda® twice daily on two symmetric lesional areas over 28 days. Response to therapy is recorded at each visit.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01079897
Study type Interventional
Source Bitop AG
Contact
Status Completed
Phase N/A
Start date March 2010
Completion date June 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT05057351 - A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis N/A
Active, not recruiting NCT03250663 - Eucrisa for Atopic Dermatitis Phase 1
Not yet recruiting NCT06052995 - Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.
Terminated NCT00996008 - CT 327 in the Treatment of Atopic Dermatitis Phase 2
Completed NCT01568489 - Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis Phase 2
Completed NCT02079688 - Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema Phase 2
Not yet recruiting NCT05729074 - A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients Phase 1
Completed NCT00568412 - A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis Phase 4